Found 9 articles for: "Minoxidil"
Injectable Minoxidil for Hair Loss Disorders: A Systematic Review
December 2024 | Volume 23 | Issue 12 | Original Article | 1084 | Copyright © December 2024
Background: Minoxidil is a frequently prescribed medication for hair loss. Although topical and oral minoxidil is widely established for treating hair loss by dermatologists, the...
Read MoreEfficacy of Topical Finasteride 0.25% With Minoxidil 5% Versus Topical Minoxidil 5% Alone in Treatment of Male Pattern Androgenic Alopecia
November 2024 | Volume 23 | Issue 11 | Original Article | 1003 | Copyright © November 2024
Background: Androgenetic Alopecia (AGA) (male pattern hair loss) is the most common form of alopecia in men, affecting 30% of men by the age of 30 years and 50% by the age of 50 ...
Read MoreEvaluation of Pericardial Effusions in Alopecia Patients on Low-Dose Oral Minoxidil Therapy
September 2024 | Volume 23 | Issue 9 | Original Article | 725 | Copyright © September 2024
Background: Minoxidil is an anti-hypertensive vasodilator increasingly used off-label for the treatment of alopecia. It is associated with an increased risk of pericardial effusi...
Read MoreResponse to "The Potential Impact of Off-Label Medication Use on Patient Access: A Cross-Sectional Survey of Minoxidil Availability"
September 2024 | Volume 23 | Issue 9 | Editorials | e175 | Copyright © September 2024
Survey of Dermatology Practitioners' Opinions and Prescribing Habits of Oral Minoxidil for the Treatment of Androgenetic Alopecia
March 2024 | Volume 23 | Issue 3 | Original Article | 136 | Copyright © March 2024
Background: Utilization of low-dose oral minoxidil has increased in recent years in association with several clinical studies that have shown its efficacy in treating androgeneti...
Read MoreOral Minoxidil Media Coverage: The Impact on Patient Perceptions and Practitioner Approaches to Androgenetic Alopecia
January 2024 | Volume 23 | Issue 1 | Editorials | 1364 | Copyright © January 2024
A Randomized Control Trial Comparing the Efficacy of Platelet-Rich Plasma and 5% Topical Minoxidil for the Treatment of Androgenetic Alopecia
September 2023 | Volume 22 | Issue 9 | Original Article | 905 | Copyright © September 2023
Androgenetic alopecia (AGA) is the most common cause of hair loss in men and has limited treatment options. Minoxidil is a common therapeutic option for AGA patients because of its availability. Plate...
Read MoreTopical Minoxidil Adherence in Patients With Alopecia
March 2023 | Volume 22 | Issue 3 | Original Article | 252 | Copyright © March 2023
Background: Non-adherence to topical minoxidil in alopecia patients is a barrier to efficacy. Understanding patient factors associated with adherence and non-adherence may provide act...
Read MoreA Survey of Patient Attitudes Towards Topical Minoxidil in the Treatment of Hair Loss
October 2022 | Volume 21 | Issue 10 | Editorials | 1140 | Copyright © October 2022
Hair loss, specifically androgenetic alopecia (AGA), is a common outpatient dermatology complaint. AGA occurs in men and women, results from the effect of dihydrotestosterone miniaturizing scalp folli...
Read More
© 2023 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
